HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TRANSTHERA-B

10.170

-0.230-2.21%

Volume:2.48M

Turnover:25.19M

Market Cap:4.14B

PE:-11.47

High:10.370

Open:10.350

Low:10.080

Close:10.400

52wk High:679.500

52wk Low:9.010

Shares:407.00M

HK Float Shares:312.00M

Volume Ratio:0.63

T/O Rate:0.79%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.887

ROE:-36.78%

ROA:-20.32%

PB:4.04

PE(LYR):-11.47

PS:100.07

Loading ...

Overview Company News Filings

TRANSTHERA-B Shares Extend Losses, Hitting New Low with Market Cap Below HK$4.5 Billion

TRANSTHERA-B Shares Plunge Approximately 60% Amid Major Shareholder Lock-Up Expiry and Three Discounted Placements in Six Months

TransThera Sets Up Strategy Committee to Tighten Governance and Guide Long-Term Investments

TransThera Sciences: All AGM Resolutions Cleared; New INED Appointed, Supervisory Committee Dissolved

Bulletin Express

Transthera Sciences files directors list with Hong Kong Stock Exchange

Appointment of Feng Weibo as Independent Non-Executive Director at TRANSTHERA-B

TransThera Sciences names Feng Weibo independent director, replacing Zheng Zhelan

TRANSTHERA-B Appoints Sun Delong as Chief Operating Officer

TransThera Sciences names Sun Delong chief operating officer

Biotech Firm TRANSTHERA-B Conducts Third Heavily Discounted Share Placement in 2024, Raising $624M HKD in Total

TRANSTHERA-B Shares Surge Over 9% Following Completion of H Share Placement Raising Approximately HK$152 Million

TRANSTHERA-B Shares Surge Over 4% Following Release of Key Phase II Data for Tenegotinib at ASCO 2026

Movement Alert｜PharmJet AnKang-B Falls 5.41% in Regular Trading, Stock Under Pressure After ASCO Presentation of Key Phase II Clinical Data

TRANSTHERA-B Unveils Key Phase II Clinical Data for Tinengotinib in Advanced Cholangiocarcinoma at 2026 ASCO

HKEX's Tech 100 Index Undergoes Semi-Annual Rebalance: Seven New Entrants Including DEEPEXI TECH

TransThera Sciences Completes HK$157 Million Share Offering

MT Newswires Live

TransThera Completes HK$156.62 Million H-Share Placement, Enlarges Share Capital by 0.94%

Bulletin Express

TRANSTHERA-B Completes Placement of 3.836 Million Shares

TransThera Sciences places 3,836,000 new H shares at HK$ 40.83 each under general mandate

TransThera Sciences Gets China Approval for Cancer Study; to Partner with Shanghai Allist Pharma on Phase 2 Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/02617/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"TRANSTHERA-B","latestPrice":10.17,"timestamp":1788163726522,"preClose":10.4,"halted":0,"volume":2479500,"delay":0,"changeRate":-0.022115384615384655,"floatShares":312000000,"shares":407000000,"eps":-0.8866825528712747,"marketStatus":"Not Yet Opened","change":-0.23,"latestTime":"08-31 16:08:46","open":10.35,"high":10.37,"low":10.08,"amount":25194615,"amplitude":0.027885,"askPrice":10.17,"askSize":48500,"bidPrice":10.16,"bidSize":29500,"shortable":3,"etf":0,"ttmEps":-0.7846837254142695,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":10.4,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.630178,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":312000000,"roa":"-20.32%","roe":"-36.78%","lyrEps":-0.886665,"volumeRatio":0.630178,"shares":407000000,"dividePrice":0,"high":10.37,"amplitude":0.027885,"preClose":10.4,"low":10.08,"week52Low":9.01,"pbRate":"4.04","psRate":"100.07","week52High":679.5,"institutionHeld":0,"latestPrice":10.17,"committee":-0.24359,"eps":-0.8866646808910907,"divideRate":0,"volume":2479500,"delay":0,"ttmEps":-0.7846679093232164,"open":10.35,"prevYearClose":114.9,"prevWeekClose":10.4,"prevMonthClose":9.95,"prevQuarterClose":11.55,"fiveDayClose":9.975,"twentyDayClose":10,"sixtyDayClose":33.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"market":"HK","date":"2026-03-31","symbol":"02617","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774886400000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2026-08-28","current":-12.960897,"percent":0.869863,"low":-380.446233,"twenty":-206.454369,"median":-79.928564,"eighty":-37.623415,"high":-10.87103,"avg":-113.01539,"sd":96.275788,"marketCap":4242353783},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-24","current":-293.038662,"twenty":-206.454369,"median":-63.574223,"eighty":-42.029097,"marketCap":75807447903},{"date":"2025-10-31","current":-281.572204,"twenty":-212.338922,"median":-65.741367,"eighty":-42.067733,"marketCap":72949784945},{"date":"2025-11-07","current":-338.772318,"twenty":-240.199465,"median":-68.232426,"eighty":-42.195906,"marketCap":87714376893},{"date":"2025-11-14","current":-312.135011,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"marketCap":81046496658},{"date":"2025-11-21","current":-312.892206,"twenty":-281.392507,"median":-71.392356,"eighty":-43.133487,"marketCap":81205255711},{"date":"2025-11-28","current":-305.66478,"twenty":-292.6573,"median":-72.756691,"eighty":-44.126885,"marketCap":79617665179},{"date":"2025-12-05","current":-292.058382,"twenty":-294.387608,"median":-99.507708,"eighty":-45.187328,"marketCap":76204345536},{"date":"2025-12-12","current":-243.995471,"twenty":-293.167092,"median":-152.573856,"eighty":-47.193393,"marketCap":63781449623},{"date":"2025-12-19","current":-248.269013,"twenty":-292.997062,"median":-174.177612,"eighty":-49.176233,"marketCap":65051522048},{"date":"2025-12-24","current":-196.609225,"twenty":-292.87226,"median":-176.029803,"eighty":-49.50215,"marketCap":51676071816},{"date":"2026-01-02","current":-170.268162,"twenty":-292.367293,"median":-176.029803,"eighty":-50.024601,"marketCap":44928812055},{"date":"2026-01-09","current":-172.395935,"twenty":-291.502465,"median":-173.687618,"eighty":-50.606284,"marketCap":45603538031},{"date":"2026-01-16","current":-142.824051,"twenty":-290.689477,"median":-172.622298,"eighty":-50.90198,"marketCap":37903723951},{"date":"2026-01-23","current":-125.658859,"twenty":-289.035292,"median":-170.268162,"eighty":-51.777834,"marketCap":33316302355},{"date":"2026-01-30","current":-123.813683,"twenty":-286.862177,"median":-169.566856,"eighty":-52.840115,"marketCap":32977154367},{"date":"2026-02-06","current":-105.494623,"twenty":-283.350344,"median":-167.82666,"eighty":-53.700055,"marketCap":28169232889},{"date":"2026-02-13","current":-102.143547,"twenty":-281.033113,"median":-142.637109,"eighty":-54.549461,"marketCap":27431087268},{"date":"2026-02-20","current":-99.091969,"twenty":-280.673719,"median":-140.820404,"eighty":-54.88737,"marketCap":26573242357},{"date":"2026-02-27","current":-101.401985,"twenty":-277.873293,"median":-135.446139,"eighty":-55.077905,"marketCap":27490936913},{"date":"2026-03-06","current":-136.499284,"twenty":-268.489172,"median":-127.818396,"eighty":-56.170035,"marketCap":36707782236},{"date":"2026-03-13","current":-113.20329,"twenty":-265.946326,"median":-125.658859,"eighty":-56.966285,"marketCap":30583168569},{"date":"2026-03-20","current":-101.699451,"twenty":-264.885138,"median":-122.419285,"eighty":-57.460964,"marketCap":27371237623},{"date":"2026-03-27","current":-103.891016,"twenty":-259.5894,"median":-118.720319,"eighty":-57.713018,"marketCap":27889934546},{"date":"2026-04-02","current":-103.689961,"twenty":-256.279611,"median":-116.735022,"eighty":-57.836913,"marketCap":27969734073},{"date":"2026-04-10","current":-80.663784,"twenty":-255.242863,"median":-113.754326,"eighty":-57.879207,"marketCap":27371237623},{"date":"2026-04-17","current":-81.335146,"twenty":-254.749157,"median":-113.20329,"eighty":-57.943799,"marketCap":27610636203},{"date":"2026-04-24","current":-69.75013,"twenty":-253.791099,"median":-110.250158,"eighty":-58.025793,"marketCap":23679242293},{"date":"2026-04-30","current":-61.379887,"twenty":-252.626844,"median":-107.193308,"eighty":-58.709304,"marketCap":20850663862},{"date":"2026-05-08","current":-65.459145,"twenty":-251.564027,"median":-106.48355,"eighty":-58.020504,"marketCap":22305361341},{"date":"2026-05-15","current":-57.457667,"twenty":-249.188687,"median":-106.083059,"eighty":-57.919993,"marketCap":19630334311},{"date":"2026-05-22","current":-50.784784,"twenty":-247.674355,"median":-104.198267,"eighty":-57.649604,"marketCap":17310899997},{"date":"2026-05-29","current":-41.763424,"twenty":-245.295721,"median":-103.852131,"eighty":-57.457667,"marketCap":14285310527},{"date":"2026-06-05","current":-37.606441,"twenty":-243.995471,"median":-103.234551,"eighty":-55.321243,"marketCap":12882070430},{"date":"2026-06-12","current":-38.299212,"twenty":-239.592317,"median":-102.28828,"eighty":-53.347698,"marketCap":13110504864},{"date":"2026-06-18","current":-33.64261,"twenty":-235.649979,"median":-102.143547,"eighty":-51.161877,"marketCap":11544097313},{"date":"2026-06-26","current":-10.87103,"twenty":-223.802745,"median":-101.125662,"eighty":-50.162538,"marketCap":3712059560},{"date":"2026-07-03","current":-14.085963,"twenty":-220.323597,"median":-100.505297,"eighty":-47.51031,"marketCap":4813439869},{"date":"2026-07-10","current":-12.489761,"twenty":-217.694001,"median":-99.314488,"eighty":-43.652943,"marketCap":4262749714},{"date":"2026-07-17","current":-11.456979,"twenty":-215.893769,"median":-98.774546,"eighty":-42.55123,"marketCap":3924177249},{"date":"2026-07-24","current":-12.133097,"twenty":-213.808047,"median":-93.131819,"eighty":-41.957553,"marketCap":4156690870},{"date":"2026-07-31","current":-11.824868,"twenty":-212.088453,"median":-87.290837,"eighty":-41.541423,"marketCap":4058790398},{"date":"2026-08-07","current":-13.332054,"twenty":-210.416628,"median":-83.155604,"eighty":-40.356892,"marketCap":4585005434},{"date":"2026-08-14","current":-12.237188,"twenty":-208.788963,"median":-82.408413,"eighty":-39.630155,"marketCap":4213799478},{"date":"2026-08-21","current":-12.186563,"twenty":-208.418403,"median":-81.461274,"eighty":-38.522204,"marketCap":4205641106},{"date":"2026-08-28","current":-13.544101,"twenty":-206.454369,"median":-79.928564,"eighty":-37.623415,"marketCap":4242353783}],"updateTime":1788196268509},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1101880330","title":"TRANSTHERA-B Shares Extend Losses, Hitting New Low with Market Cap Below HK$4.5 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1101880330","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101880330?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:52","pubTimestamp":1782269547,"startTime":"0","endTime":"0","summary":"Shares of TRANSTHERA-B (02617) continued their decline, falling over 4% during the morning session to hit a new low of HK$10.51. This follows a steep drop of nearly 60% in the previous trading day....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1161","02617","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100203407","title":"TRANSTHERA-B Shares Plunge Approximately 60% Amid Major Shareholder Lock-Up Expiry and Three Discounted Placements in Six Months","url":"https://stock-news.laohu8.com/highlight/detail?id=1100203407","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100203407?lang=en_us&edition=fundamental","pubTime":"2026-06-23 13:11","pubTimestamp":1782191461,"startTime":"0","endTime":"0","summary":"The lock-up period for TRANSTHERA-B (02617) entered its second stage of expiry on June 23, marking one year since its listing. According to the company's shareholder information as of December 31,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644098086","title":"TransThera Sets Up Strategy Committee to Tighten Governance and Guide Long-Term Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2644098086","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644098086?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:14","pubTimestamp":1781788486,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing). Inc. ( ($HK:2617) ) has issued an announcement. TransThera Sciences (Nanjing), Inc. has established a Strategy Commi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transthera-sets-up-strategy-committee-to-tighten-governance-and-guide-long-term-investments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transthera-sets-up-strategy-committee-to-tighten-governance-and-guide-long-term-investments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166997581","title":"TransThera Sciences: All AGM Resolutions Cleared; New INED Appointed, Supervisory Committee Dissolved","url":"https://stock-news.laohu8.com/highlight/detail?id=1166997581","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166997581?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:46","pubTimestamp":1781786774,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing), Inc. (TransThera) announced that shareholders approved every item on the agenda at the 18 June 2026 Annual General Meeting (AGM), endorsing both operational and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644083773","title":"Transthera Sciences files directors list with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2644083773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644083773?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:28","pubTimestamp":1781785733,"startTime":"0","endTime":"0","summary":"Transthera Sciences  filed an updated list of directors with the Hong Kong Stock Exchange on June 18, 2026.Board lineup: executive directors Dr. Frank Wu, Wu Di; non-executive director Jia Zhongxin; independent non-executive directors Chui Hoi Yam, Li Shu Pai, Feng Weibo.Committee roles: Frank Wu chairs the strategy committee; Li Shu Pai chairs the audit committee; Feng Weibo chairs the remuneration and appraisal committee.Nomination committee chaired by Chui Hoi Yam; Frank Wu, Feng Weibo serve as members.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 18","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL56c58L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0010","BK0215","BK1095","BK1615","BK0082","BK1161","09898","02617","BK0102","600962","BK0081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144424771","title":"Appointment of Feng Weibo as Independent Non-Executive Director at TRANSTHERA-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1144424771","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144424771?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:28","pubTimestamp":1781785700,"startTime":"0","endTime":"0","summary":"Following the approval at the Annual General Meeting, Mr. Feng Weibo has been appointed as an Independent Non-Executive Director of the second-term board of directors at TRANSTHERA-B (ASX:...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644083731","title":"TransThera Sciences names Feng Weibo independent director, replacing Zheng Zhelan","url":"https://stock-news.laohu8.com/highlight/detail?id=2644083731","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644083731?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:24","pubTimestamp":1781785487,"startTime":"0","endTime":"0","summary":"Transthera Sciences  appointed Feng Weibo as an independent non-executive director, effective June 18, 2026, replacing Zheng Zhelan.Feng also took over as chair of the remuneration and appraisal committee.He joined the audit committee, joined the nomination committee.Zheng stepped down as remuneration and appraisal committee chair, exited the audit committee, exited the nomination committee at the AGM’s close.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL2P4Pwp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1095","BK1161","BK1615","09898","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101057331","title":"TRANSTHERA-B Appoints Sun Delong as Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=1101057331","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101057331?lang=en_us&edition=fundamental","pubTime":"2026-06-12 21:26","pubTimestamp":1781270775,"startTime":"0","endTime":"0","summary":"The board of directors of TRANSTHERA-B (02617) has announced the appointment of Mr. Sun Delong as the company's Chief Operating Officer, effective from June 12, 2026.In this role, Mr. Sun will be...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642955742","title":"TransThera Sciences names Sun Delong chief operating officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642955742","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642955742?lang=en_us&edition=fundamental","pubTime":"2026-06-12 21:21","pubTimestamp":1781270500,"startTime":"0","endTime":"0","summary":"Transthera Sciences  named Sun Delong chief operating officer, effective June 12, 2026.Earlier roles included deputy general manager at Liaoning Herbpex Pharmaceutical Group, national sales head at Jiangsu Simcere Pharmaceutical.Holds a bachelor’s degree in pharmacy from Shenyang Pharmaceutical University.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL7dxm29:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02096","BK1191","BK1583","BK1606","02186","WHIB","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155616891","title":"Biotech Firm TRANSTHERA-B Conducts Third Heavily Discounted Share Placement in 2024, Raising $624M HKD in Total","url":"https://stock-news.laohu8.com/highlight/detail?id=1155616891","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155616891?lang=en_us&edition=fundamental","pubTime":"2026-06-12 11:21","pubTimestamp":1781234482,"startTime":"0","endTime":"0","summary":"The biotech company TRANSTHERA-B (02617.HK), listed under the Hong Kong exchange's Chapter 18A rules, has once again tapped the capital markets.On May 27, 2024, the company announced it had placed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134400927","title":"TRANSTHERA-B Shares Surge Over 9% Following Completion of H Share Placement Raising Approximately HK$152 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1134400927","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134400927?lang=en_us&edition=fundamental","pubTime":"2026-06-08 10:10","pubTimestamp":1780884651,"startTime":"0","endTime":"0","summary":"Shares of TRANSTHERA-B (02617) surged by more than 14% during the trading session. At the time of writing, the stock is up 8.87%, trading at HK$34.38. Recently, TRANSTHERA-B (02617) announced the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157870740","title":"TRANSTHERA-B Shares Surge Over 4% Following Release of Key Phase II Data for Tenegotinib at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1157870740","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157870740?lang=en_us&edition=fundamental","pubTime":"2026-06-08 09:55","pubTimestamp":1780883744,"startTime":"0","endTime":"0","summary":"Shares of TRANSTHERA-B (ASX: 02617) have risen by more than 4%. At the time of writing, the stock is up 4.05% to HK$32.74, with a trading volume of HK$45.26 million.The recent price movement follows...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VXUS","02617","BK4585","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142379650","title":"Movement Alert｜PharmJet AnKang-B Falls 5.41% in Regular Trading, Stock Under Pressure After ASCO Presentation of Key Phase II Clinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1142379650","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142379650?lang=en_us&edition=fundamental","pubTime":"2026-06-05 15:22","pubTimestamp":1780644135,"startTime":"0","endTime":"0","summary":"On June 5, PharmJet AnKang-B (Yaojie Ankang-B) declined 5.41% in regular trading, trading at HK$32.14 per share, with trading volume of approximately HK$73.33 million.On the news front, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126409720","title":"TRANSTHERA-B Unveils Key Phase II Clinical Data for Tinengotinib in Advanced Cholangiocarcinoma at 2026 ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=1126409720","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126409720?lang=en_us&edition=fundamental","pubTime":"2026-05-31 18:10","pubTimestamp":1780222228,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (02617) has announced the presentation of its latest research findings for its core product, tinengotinib, at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108594441","title":"HKEX's Tech 100 Index Undergoes Semi-Annual Rebalance: Seven New Entrants Including DEEPEXI TECH","url":"https://stock-news.laohu8.com/highlight/detail?id=1108594441","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108594441?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:15","pubTimestamp":1780053358,"startTime":"0","endTime":"0","summary":"On May 29, Hong Kong Exchanges and Clearing Limited (HKEX) announced the results of the semi-annual review for the HKEX Tech 100 Index. The index will add seven technology stocks: DEEPEXI TECH...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1642822792.SGD","LU0320764599.SGD","BK1610","LU0762542818.HKD","IE00BKZH1Z71.USD","LU0577902454.USD","LU0164939612.USD","LU0359202008.SGD","LU0594300419.USD","LU0348735423.USD","BK1589","LU0261947096.USD","02525","LU0821914370.USD","LU0577902298.EUR","LU1048588211.SGD","LU1051768304.USD","LU1807302812.USD","LU0348814723.USD","LU0211977185.USD","LU0274383008.USD","LU0348766576.USD","LU0370786039.SGD","LU1515016050.SGD","LU2226246903.HKD","LU0210527791.USD","LU0856984785.SGD","LU0979878070.USD","BK1149","02590","LU0417516738.SGD","LU0516423091.SGD","LU0384037296.USD","LU0630378429.USD","LU1105468828.SGD","LU0516422440.USD","LU0067412154.USD","LU0348827113.USD","LU0651947912.USD","SG9999004220.SGD","80388","BK1144","LU0165289439.USD","LU1044876610.USD","BK1183","LU1048596156.SGD","LU0791590937.USD","LU0417516902.SGD","LU1242518857.USD","HSAI","LU0577902538.SGD","LU0314109678.HKD","02643","LU0061477393.USD","LU0577902371.SGD","LU1734074674.USD","LU0588546209.SGD","LU0577902611.USD","LU0918141705.HKD","LU0117844026.USD","LU2039709279.SGD","BK1117","LU0955648018.USD","SG9999002463.SGD","LU1481107354.HKD","LU0819121731.USD","LU0348825331.USD","LU1044875133.USD","LU1282649810.SGD","LU1813983027.USD","LU2449936058.SGD","BK1523","LU0708995583.HKD","LU0072913022.USD","LU0501845795.SGD","LU1130305938.SGD","SG9999001093.SGD","01729","LU1226287529.USD","SG9999001846.SGD","LU0620787316.HKD","IE00BZ08YS42.EUR","LU1044874839.SGD","SG9999002562.SGD","LU0762540952.USD","LU0634319403.HKD","LU0082770016.USD","LU0011963245.USD","HK0000107257.USD","LU0762541174.USD","LU0197773160.USD","BK1506","LU0456846285.SGD","LU0831093199.SGD","LU1655091459.SGD","HKXCY","LU0197773673.USD","LU0082770016.SGD","BK1161","LU1366334651.USD","LU0797268264.HKD","LU0096374516.USD","LU1328277881.USD","06869","LU0831103253.SGD","IE0003795394.USD","LU0648948544.HKD","LU0072462343.USD","BK1131","LU0307460666.USD","SGXZ90724238.SGD","IE00B3T34201.USD","LU1023057109.AUD","LU0873338254.USD","LU0516423174.USD","LU0516422952.EUR","LU0327786744.USD","LU1504937902.USD","LU0359201885.HKD","02617","LU1993786604.SGD","BK1255","IE0003851619.USD","LU0540923850.HKD","LU0084288322.USD","BK1521","LU2257852520.SGD","LU0048597586.USD","LU0149721374.USD","601869","LU1981816686.USD","LU0488056044.USD","LU0251144936.SGD","LU0169518387.USD","LU0819123356.HKD","LU0117841782.USD","LU0630378692.HKD","LU1366334578.USD","LU0955669360.SGD","LU0561508036.HKD","LU0348816934.USD","LU1051769294.HKD","LU0791591158.USD","00388","LU0048580855.USD","LU0594300179.USD","IE00BZ08YT58.USD","LU1242518931.SGD","BK1116","LU0607220059.USD","LU1282648689.USD","LU0605514214.HKD","LU0164880469.USD","LU0784639295.USD","SG9999006597.SGD","LU0140636845.USD","SG9999001051.SGD","LU0898667661.SGD","LU0886674414.USD","LU1831875114.USD","LU0651946864.USD","LU1211504680.USD","LU0052750758.USD","LU0149534421.HKD","LU0955623706.USD","01384","LU0516422366.SGD","LU0196878994.USD","LU0572944931.SGD","HK0000151867.HKD","LU1282649067.USD","LU0359201612.USD","LU0918141887.USD","LU0106959298.USD","IE00BZ08YR35.GBP","LU1282649141.HKD","LU0650527681.SGD","LU0348767384.USD","LU0043850808.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638512654","title":"TransThera Sciences Completes HK$157 Million Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2638512654","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638512654?lang=en_us&edition=fundamental","pubTime":"2026-05-28 12:56","pubTimestamp":1779944187,"startTime":"0","endTime":"0","summary":"TransThera Sciences   said it completed a HK$156.6 million share offering, according to a Wednesday filing with the Hong Kong bourse.The drugmaker's shares fell over 5% in late morning trade Thursday.The company sold 3.8 million shares priced at HK$40.83 each to raise funds for the development of new indications for its core product, tinengotinib.The shares represent 1.23% of the company's existing H shares and 0.94% of its enlarged share capital.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182101486","title":"TransThera Completes HK$156.62 Million H-Share Placement, Enlarges Share Capital by 0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182101486","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182101486?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:02","pubTimestamp":1779886972,"startTime":"0","endTime":"0","summary":"TransThera Sciences (Nanjing), Inc. (TransThera) has finalised the placement of 3.84 million new H shares at HK$40.83 each, generating gross proceeds of HK$156.62 million. Net of fees and expenses,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184062559","title":"TRANSTHERA-B Completes Placement of 3.836 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1184062559","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184062559?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:58","pubTimestamp":1779886734,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (02617) has announced that all conditions under the placement agreement have been fulfilled, and the placement was completed on May 27, 2026. The placing agent successfully placed a total of 3.836 million shares to no fewer than six placees at a placing price of HK$40.83 per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638688216","title":"TransThera Sciences places 3,836,000 new H shares at HK$ 40.83 each under general mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=2638688216","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638688216?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:55","pubTimestamp":1779886533,"startTime":"0","endTime":"0","summary":"Transthera Sciences  completed a placement of 3,836,000 new H shares at HK$ 40.83 per share on May 27, 2026.Gross proceeds totaled HK$ 156.62 million; net proceeds were HK$ 152.13 million, implying a net issue price of HK$ 39.66.Net proceeds earmarked 90% for Tinengotinib new-indication development; 10% for working capital and general corporate purposes.Placed to at least six investors; none became a substantial shareholder immediately following completion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 27, 2026, and is solely responsible for the informati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL2Lt9qs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638579576","title":"TransThera Sciences Gets China Approval for Cancer Study; to Partner with Shanghai Allist Pharma on Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2638579576","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638579576?lang=en_us&edition=fundamental","pubTime":"2026-05-27 13:54","pubTimestamp":1779861286,"startTime":"0","endTime":"0","summary":"TransThera Sciences   said Chinese regulators approved its phase 2 clinical trial of tinengotinib to treat prostate cancer, according to a Tuesday filing with the Hong Kong bourse.The company's shares fell over 3% in afternoon trade Wednesday.The firm will evaluate a combination of tinengotinib and novel hormone therapy in an open-label study in subjects with metastatic castration-resistant prostate cancer.In a separate announcement, the firm said it is partnering with Shanghai Allist Pharmaceuticals on another open-label phase 2 study to evaluate TT-00973-MS tablets in combination with firmonertinib mesylate tablets in patients with locally advanced or metastatic non-small cell lung cancer.Based on the results of the study, the parties may collaborate on a phase 3 study.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":148,"code":"91000000","status":"200"}]}}